We partner with entrepreneurs, academics, and engineers to turn their groundbreaking ideas into dominant businesses that span the tech and bio ecosystem.
I wanted to hear why Goulburn and Dar, general partners at Lux Capital, and Li, a general partner at Obvious Ventures, decided to embark on the long, hard trek of building their own firm.
NewYork BIO's breakfast series has gone virtual! Providing engaging speakers on innovation, clinical development, patient engagement and more cutting topics across the biopharmaceutical industry.
Adam Goulburn is the co-founder and Managing Partner of Dimension, a $300 million fund focused on investing in companies at the intersection of medicine and data science.